Literature DB >> 8835575

A syndrome of fibrosing pleuritis, pericarditis, and synovitis with infantile contractures of fingers and toes in 2 sisters: "familial fibrosing serositis".

U N Verma1, R Misra, S Radhakrisnan, S C Maitra, S S Agarwal, R R Singh.   

Abstract

We describe a family in which 2 sisters born to consanguineous parents developed childhood onset fibrosing pleuritis in association with constrictive pericarditis and bilateral deforming arthropathy of large and small joints of upper and lower extremities including flexion contractures of several fingers (camptodactyly) and toes. One patient also had mitral value prolapse. Histopathological examination of the synovium and pericardium revealed fibrosis, and ultrastructural study of synovium showed abundant inter and intracellular mesh of 9 nm microfibrils. We describe this distinct clinicopathological entity with pleiotropic manifestations, the common features of which appears to be the fibrosis of serous membranes. Therefore, the term "familial fibrosing serositis" is proposed for this entity.

Entities:  

Mesh:

Year:  1995        PMID: 8835575

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  3 in total

1.  Camptodactyly, arthropathy, coxa vara, pericarditis (CACP)syndrome: a case report.

Authors:  Byung Ryul Choi; Young Hyo Lim; Kyung Bin Joo; Seung Sam Paik; Nam Su Kim; Je Kyung Lee; Dae Hyun Yoo
Journal:  J Korean Med Sci       Date:  2004-12       Impact factor: 2.153

2.  Transcriptional regulation of proteoglycan 4 by 17β-estradiol in immortalized baboon temporomandibular joint disc cells.

Authors:  Jennifer S McDaniel; Ramya Akula Suresh Babu; Mary M Navarro; Richard G LeBaron
Journal:  Eur J Oral Sci       Date:  2014-04       Impact factor: 2.612

3.  Novel mutations in PRG4 gene in two Indian families with camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome.

Authors:  Rajashree S Nandagopalan; Shubha R Phadke; Ashwin B Dalal; Prajnya Ranganath
Journal:  Indian J Med Res       Date:  2014-08       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.